methacycline has been researched along with phosphotyrosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bruder, J; Foster, DA; Gupta, R; Hendrickson, M; Joseph, CK; Qureshi, SA; Rapp, U; Song, J | 1 |
Aussel, C; Breittmayer, JP; Pelassy, C; Rouquette-Jazdanian, AK | 1 |
2 other study(ies) available for methacycline and phosphotyrosine
Article | Year |
---|---|
A dominant negative Raf-1 mutant prevents v-Src-induced transformation.
Topics: 3T3 Cells; Animals; Cell Transformation, Neoplastic; Cells, Cultured; Diglycerides; Genes, Dominant; Mice; Mice, Inbred BALB C; Mutation; Oncogene Protein pp60(v-src); Phosphotyrosine; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Tyrosine | 1993 |
Full CD3/TCR activation through cholesterol-depleted lipid rafts.
Topics: Adaptor Proteins, Signal Transducing; Biomarkers; Calcium Signaling; CD3 Complex; Cell Survival; Ceramides; Cholesterol; Cytoskeleton; Cytosol; Diglycerides; Humans; Hydrolysis; Interleukin-2 Receptor alpha Subunit; Jurkat Cells; MAP Kinase Kinase 1; Membrane Microdomains; Membrane Proteins; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phospholipase C gamma; Phosphotyrosine; Proto-Oncogene Proteins c-vav; Receptors, Antigen, T-Cell; Sphingomyelin Phosphodiesterase; Sphingomyelins | 2007 |